A five-level evidence framework is applied to distinguish HCC-specific mechanistic and in vivo evidence, HCC functional and cell-based findings, HCC clinical and omics associations, pan-cancer or non-HCC evidence, and hypothesis-generating candidates, highlighting the uneven maturity of the field.
Xiao-Peng Chen, Bao-Ding Li, Hao Chai et al.· Journal of Hepatocellular Ca...· 0 citations
Current research findings on the cellular composition, spatial structure, and regulatory mechanisms of the immunosuppressive microenvironment are summarized and the emerging clinical value of space biomarkers and interaction networks in patient stratification, therapeutic target identification, and precision immunother...
Hao Chai, Lang Wu, Xiaopeng Chen et al.· Frontiers in Immunology· 0 citations
A conceptual framework is proposed in which TK1 is viewed not merely as a proliferation marker but as a potential regulator of the metabolic–immune ecosystem in HCC, which may facilitate the development of novel biomarkers and precision therapeutic strategies for patients with HCC.
Hao Chai, Lang Wu, Ming-Hao Li· Discover Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.